Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Int. braz. j. urol ; 43(2): 356-366, Mar.-Apr. 2017. tab, graf
Article Dans Anglais | LILACS | ID: biblio-840829

Résumé

ABSTRACT Purpose To investigate the lower urinary tract changes in mice treated with L-NAME, a non-selective competitive inhibitor of nitric oxide synthase (NOS), or aminoguanidine, a competitive inhibitor of inducible nitric oxide synthase (iNOS), after 5 weeks of partial bladder outlet obstruction (BOO), in order to evaluate the role of constitutive and non-constitutive NOS in the pathogenesis of this experimental condition. Materials and Methods C57BL6 male mice were partially obstructed and randomly allocated into 6 groups: Sham, Sham + L-NAME, Sham + aminoguanidine, BOO, BOO + L-NAME and BOO + aminoguanidine. After 5 weeks, bladder weight was obtained and cystometry and tissue bath contractile studies were performed. Results BOO animals showed increase of non-voiding contractions (NVC) and bladder capacity, and also less contractile response to Carbachol and Electric Field Stimulation. Inhibition of NOS isoforms improved bladder capacity and compliance in BOO animals. L-NAME caused more NVC, prevented bladder weight gain and leaded to augmented contractile responses at muscarinic and electric stimulation. Aminoguanidine diminished NVC, but did not avoid bladder weight gain in BOO animals and did not improve contractile responses. Conclusion It can be hypothesized that chronic inhibition of three NOS isoforms in BOO animals leaded to worsening of bladder function, while selective inhibition of iNOS did not improve responses, what suggests that, in BOO animals, alterations are related to constitutive NOS.


Sujets)
Animaux , Mâle , Obstruction du col de la vessie/traitement médicamenteux , Nitric oxide synthase/antagonistes et inhibiteurs , L-NAME/pharmacologie , Antienzymes/pharmacologie , Symptômes de l'appareil urinaire inférieur/traitement médicamenteux , Guanidines/pharmacologie , Monoxyde d'azote/antagonistes et inhibiteurs , Pression , Facteurs temps , Miction/effets des médicaments et des substances chimiques , Miction/physiologie , Vessie urinaire/effets des médicaments et des substances chimiques , Vessie urinaire/physiopathologie , Obstruction du col de la vessie/physiopathologie , Répartition aléatoire , Reproductibilité des résultats , Résultat thérapeutique , L-NAME/usage thérapeutique , Antienzymes/usage thérapeutique , Guanidines/usage thérapeutique , Souris de lignée C57BL , Contraction musculaire/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
Détails de la recherche